60
Participants
Start Date
October 31, 2011
Primary Completion Date
November 30, 2018
Study Completion Date
November 30, 2018
177Lu-DOTA-TATE
"177Lu-DOTA-TATE given as intravenous infusion given during 3-5 treatments. Evaluation is performed after every single cycle. Further more, evaluation is made after last cycle, and delivered cumulative dose to kidneys should be 27 Gy.~Patients with stable disease or partial response, and without pronounced toxicity will continue treatment to a step 2, where additional 3-5 treatment cycles are given, with a cumulative dose to kidneys to 40 Gy."
Sahlgrenska University Hospital, Department of Oncology, Gothenburg
Department of Oncology, Lund University Hospital, Lund
Lund University Hospital
OTHER